YAP and β-catenin cooperate to drive H. pylori-induced gastric tumorigenesis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:1–21. doi:10.3322/caac.21492.
   Web of Science ®Google Scholar
• Crowe SE, Solomon CG. Helicobacter pylori infection. N Engl J Med. 2019;380:1158–1165. doi:10.1056/NEJMcp1710945.
   PubMed Web of Science ®Google Scholar
• Correa P, Piazuelo MB. Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol Hepatol Rev. 2011;7:59–64.
   PubMedGoogle Scholar
• Lee YC, Dore MP, Graham DY. Diagnosis and treatment of helicobacter pylori infection. Annu Rev Med. 2022;73:183–195. doi:10.1146/annurev-med-042220-020814.
   PubMed Web of Science ®Google Scholar
• Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet. 2021;66:887–899. doi:10.1038/s10038-021-00960-8.
   PubMed Web of Science ®Google Scholar
• Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, You J, Wong BCY, Chen J, Ye W. Effect of helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology. 2022;163(1):154–162.e3. doi:10.1053/j.gastro.2022.03.039.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chang WJ, Chen SL, Yen AM, Fann JC, Chiu SY, Chen YR, Chuang SL, Shieh CF, Liu CY, et al. Mass eradication of helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021;70:243–250. doi:10.1136/gutjnl-2020-322200.
   PubMed Web of Science ®Google Scholar
• Li N, Feng Y, Hu Y, He C, Xie C, Ouyang Y, Artim SC, Huang D, Zhu Y, Luo Z, et al. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway. J Exp Clin Cancer Res. 2018;37:280. doi:10.1186/s13046-018-0962-5.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen H, Yu J, Kang W, To KF. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers. Biochim Biophys Acta Rev Cancer. 2022;1877:188787. doi:10.1016/j.bbcan.2022.188787.
   PubMed Web of Science ®Google Scholar
• Wu Z, Guan KL. Hippo signaling in embryogenesis and development. Trends Biochem Sci. 2021;46:51–63. doi:10.1016/j.tibs.2020.08.008.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Pan D. The hippo signaling pathway in development and disease. Dev Cell. 2019;50:264–282. doi:10.1016/j.devcel.2019.06.003.
   PubMed Web of Science ®Google Scholar
• Hyun J, Al Abo M, Dutta RK, Oh SH, Xiang K, Zhou X, Maeso-Diaz R, Caffrey R, Sanyal AJ, Freedman JA, et al. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. J Hepatol. 2021;75:623–633. doi:10.1016/j.jhep.2021.04.033.
   PubMed Web of Science ®Google Scholar
• Fang L, Teng H, Wang Y, Liao G, Weng L, Li Y, Wang X, Jin J, Jiao C, Chen L, et al. Set1A-Mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis. Cancer Cell. 2018;34:103–18 e9. doi:10.1016/j.ccell.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3. doi:10.1038/s41392-021-00762-6.
   PubMed Web of Science ®Google Scholar
• Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Wnt/beta-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6:307. doi:10.1038/s41392-021-00701-5.
   PubMed Web of Science ®Google Scholar
• Cao L, Zhu S, Lu H, Soutto M, Bhat N, Chen Z, Peng D, Lin J, Lu J, Li P, et al. Helicobacter pylori–induced RASAL2 through activation of nuclear Factor-κB promotes gastric tumorigenesis via β-catenin signaling Axis. Gastroenterology. 2022;162:1716–31 e17. doi:10.1053/j.gastro.2022.01.046.
   PubMed Web of Science ®Google Scholar
• Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, Hu CJ, Dong H, Yang SM. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016;374:292–303. doi:10.1016/j.canlet.2016.02.032.
   PubMed Web of Science ®Google Scholar
• Li N, Lu N, Xie C. The Hippo and Wnt signalling pathways: crosstalk during neoplastic progression in gastrointestinal tissue. FEBS J. 2019;286:3745–3756. doi:10.1111/febs.15017.
   PubMed Web of Science ®Google Scholar
• Tao J, Calvisi DF, Ranganathan S, Cigliano A, Zhou L, Singh S, Jiang L, Fan B, Terracciano L, Armeanu-Ebinger S, et al. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology. 2014;147:690–701. doi:10.1053/j.gastro.2014.05.004.
   PubMed Web of Science ®Google Scholar
• Quinn HM, Vogel R, Popp O, Mertins P, Lan L, Messerschmidt C, Landshammer A, Lisek K, Chateau-Joubert S, Marangoni E, et al. YAP and β-catenin cooperate to drive oncogenesis in basal breast cancer. Cancer Res. 2021;81:2116–2127. doi:10.1158/0008-5472.CAN-20-2801.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–w102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179–183. doi:10.1038/nature10137.
   PubMed Web of Science ®Google Scholar
• Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol. 2003;13:680–685. doi:10.1016/s0960-9822(03)00240-9.
   PubMed Web of Science ®Google Scholar
• Li N, Ouyang Y, Chen S, Peng C, He C, Hong J, Yang X, Zhu Y, Lu NH. Integrative analysis of differential lncRNA/mRNA expression profiling in helicobacter pylori infection-associated gastric carcinogenesis. Front Microbiol. 2020;11:880. doi:10.3389/fmicb.2020.00880.
   PubMed Web of Science ®Google Scholar
• Xie C, Li N, Wang H, He C, Hu Y, Peng C, Ouyang Y, Wang D, Xie Y, Chen J, et al. Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection. Gut Microbes. 2020;11:1567–1589. doi:10.1080/19490976.2020.1774311.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X. Targeting the Wnt/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165. doi:10.1186/s13045-020-00990-3.
   PubMed Web of Science ®Google Scholar
• Zhu S, Soutto M, Chen Z, Peng D, Romero-Gallo J, Krishna US, Belkhiri A, Washington MK, Peek R, El-Rifai W. Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32. Gut. 2017;66:761–762. doi:10.1136/gutjnl-2016-312141.
   PubMed Web of Science ®Google Scholar
• Li N, Xu X, Yang H, Wang H, Ouyang Y, Zhou Y, Peng C, Yuan Z, He C, Zeng C, et al. Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial-mesenchymal transition via the MEK/ERK pathway. Helicobacter. 2021;26:e12842. doi:10.1111/hel.12842.
   PubMed Web of Science ®Google Scholar
• Ma S, Meng Z, Chen R, Guan KL. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577–604. doi:10.1146/annurev-biochem-013118-111829.
   PubMed Web of Science ®Google Scholar
• Rim EY, Clevers H, Nusse R. The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem. 2022;91:571–598. doi:10.1146/annurev-biochem-040320-103615.
   PubMed Web of Science ®Google Scholar
• Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, et al. β-catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell. 2012;151:1457–1473. doi:10.1016/j.cell.2012.11.026.
   PubMed Web of Science ®Google Scholar
• Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X, He F, Wang Y, Zhang Z, Wang W, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014;25:166–180. doi:10.1016/j.ccr.2014.01.010.
   PubMed Web of Science ®Google Scholar
• Cha PH, Cho YH, Lee SK, Lee J, Jeong WJ, Moon BS, Yun JH, Yang JS, Choi S, Yoon J, et al. Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation. Nat Chem Biol. 2016;12:593–600. doi:10.1038/nchembio.2103.
   PubMed Web of Science ®Google Scholar
• Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 2005;65:10709–10715. doi:10.1158/0008-5472.CAN-05-1846.
   PubMed Web of Science ®Google Scholar
• Han T, Jing X, Bao J, Zhao L, Zhang A, Miao R, Guo H, Zhou B, Zhang S, Sun J, et al. H. pylori infection alters repair of DNA double-strand breaks via SNHG17. J Clin Invest. 2020;130:3901–3918. doi:10.1172/JCI125581.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–60. doi:10.1093/nar/gkz430.
   PubMed Web of Science ®Google Scholar
• Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W, Takahashi-Kanemitsu A, Knight CT, Kunita A, Suzuki N, et al. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host & Microbe. 2021;29:941–58 e10. doi:10.1016/j.chom.2021.04.006.
   PubMed Web of Science ®Google Scholar
• Molina-Castro SE, Tiffon C, Giraud J, Boeuf H, Sifre E, Giese A, Belleannee G, Lehours P, Bessede E, Megraud F, et al. The hippo kinase LATS2 controls helicobacter pylori-induced epithelial-mesenchymal transition and intestinal metaplasia in gastric mucosa. Cell Mol Gastroenterol Hepatol. 2020;9:257–276. doi:10.1016/j.jcmgh.2019.10.007.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu H, Cui G, Liang B, Chen X, Ko S, Affo S, Song X, Liao Y, Feng J, et al. β-catenin sustains and is required for YES-associated protein oncogenic activity in cholangiocarcinoma. Gastroenterology. 2022;163:481–494. doi:10.1053/j.gastro.2022.04.028.
   PubMed Web of Science ®Google Scholar
• Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. Embo J. 2012;31:1109–1122. doi:10.1038/emboj.2011.487.
   PubMed Web of Science ®Google Scholar
• Deng F, Peng L, Li Z, Tan G, Liang E, Chen S, Zhao X, Zhi F. YAP triggers the Wnt/beta-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death Dis. 2018;9:153. doi:10.1038/s41419-017-0244-8.
   PubMed Web of Science ®Google Scholar
• Pan JX, Xiong L, Zhao K, Zeng P, Wang B, Tang FL, Sun D, Guo HH, Yang X, Cui S, et al. YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling. Bone Res. 2018;6:18. doi:10.1038/s41413-018-0018-7.
   PubMed Web of Science ®Google Scholar
• Chen HY, Hu Y, Lu NH, Zhu Y. Caudal type homeoboxes as a driving force in Helicobacter pylori infection-induced gastric intestinal metaplasia. Gut Microbes. 2020;12:1–12. doi:10.1080/19490976.2020.1809331.
   Web of Science ®Google Scholar
• Chen HY, Hu Y, Xu XB, Zhou YA, Li NS, He C, Xie C, Lu NH, Zhu Y. Upregulation of oncogene Activin a receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2. Helicobacter. 2021;26:e12849. doi:10.1111/hel.12849.
   PubMed Web of Science ®Google Scholar
• Guillermin O, Angelis N, Sidor CM, Ridgway R, Baulies A, Kucharska A, Antas P, Rose MR, Cordero J, Sansom O, et al. Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration. Embo J. 2021;40:e105770. doi:10.15252/embj.2020105770.
   PubMed Web of Science ®Google Scholar
• Sigal M, Rothenberg ME, Logan CY, Lee JY, Honaker RW, Cooper RL, Passarelli B, Camorlinga M, Bouley DM, Alvarez G, et al. Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands. Gastroenterology. 2015;148:1392–404 e21. doi:10.1053/j.gastro.2015.02.049.
   PubMed Web of Science ®Google Scholar
• Zhang R, Cheung CY, Seo SU, Liu H, Pardeshi L, Wong KH, Chow LMC, Chau MP, Wang Y, Lee AR, et al. RUVBL1/2 complex regulates pro-inflammatory responses in macrophages via regulating histone H3K4 trimethylation. Front Immunol. 2021;12:679184. doi:10.3389/fimmu.2021.679184.
   PubMedGoogle Scholar
• Chakravarti D, Hu B, Mao X, Rashid A, Li J, Li J, Liao WT, Whitley EM, Dey P, Hou P, et al. Telomere dysfunction activates YAP1 to drive tissue inflammation. Nat Commun. 2020;11:4766. doi:10.1038/s41467-020-18420-w.
   PubMed Web of Science ®Google Scholar
• Cho YH, Ro EJ, Yoon JS, Kwak DK, Cho J, Kang DW, Lee HY, Choi KY. Small molecule-induced simultaneous destabilization of beta-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells. Cell Commun Signal. 2020;18:38. doi:10.1186/s12964-020-0519-z.
   PubMed Web of Science ®Google Scholar
• Ryu WJ, Lee JD, Park JC, Cha PH, Cho YH, Kim JY, Sohn JH, Paik S, Choi KY. Destabilization of beta-catenin and RAS by targeting the Wnt/beta-catenin pathway as a potential treatment for triple-negative breast cancer. Exp Mol Med. 2020;52:832–842. doi:10.1038/s12276-020-0440-y.
   PubMed Web of Science ®Google Scholar